Article thumbnail

Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells

By Wataru Habano, Toshie Gamo, Jun Terashima, Tamotsu Sugai, Koki Otsuka, Go Wakabayashi and Shogo Ozawa
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3053268
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). 5’ diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site. Mol Cell Biochem
  2. (1999). Bodmer WF: Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1. Proc Natl Acad Sci USA
  3. (2007). Broad but distinct role of pregnane X receptor on the expression of individual cytochrome P450 in human hepatocytes. Drug Metab Pharmacokinet
  4. (2008). Bulun SE: CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activityMol Cell. Endocrinol
  5. (2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA
  6. (1987). CpG islands in vertebrate genomes.
  7. (2006). DC: Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines. Pharmacogenet Genomics
  8. (2001). E: Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol
  9. (2010). Evrard A: Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer
  10. (2010). Explaining inter-individual variability in phenotype: Is epigenetics up to the challenge? Epigenetics
  11. (2006). Identification of regulatory sites in the human PXR (NR1I2) promoter region. Mol Cell Biochem
  12. (2004). Kivistö KT: Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther
  13. (2008). Krasowski MD: PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics
  14. (1999). LS: Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos
  15. (2005). Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res
  16. (1997). PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res
  17. (2009). S: CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers.
  18. (1996). T: A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab Invest
  19. (2008). The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol
  20. (2009). The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal
  21. (2009). Tian Y: Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1.
  22. (2010). Tian Y: Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells.
  23. (2002). TM: The nuclear pregnane X receptor: ak e yr e g u l a t o ro fx e n o b i o t i cm e t a b o l i s m .Endocr Rev
  24. (2006). Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab Dispos
  25. (1993). Two nuclear signalling pathways for vitamin D. Nature